) This is a new facility to be located in recently renovated space. For several years, one laboratory (Dr. Lees) has served as a resource helping other groups to generate monoclonals. Monoclonal antibodies are a fundamental tool in establishing the precise role of proteins in vivo. The need to provide this as a shared facility is clear. A central facility will ensure maintenance of well tested and reliable myeloma cell lines, serum and other reagents that will greatly improve efficiency and cost effectiveness of the fusions. This will also allow production of antibodies that would otherwise not be generated because of lack of expertise and, in that way, significantly enhance the progress of the research. The facility will operate as a near full service unit using the standard operating protocol defined by the Lees lab. It will conduct most of the steps of monoclonal production including- (1) injection and bleeding of mice, (2) hybridoma fusions, (3) primary ELISA screening, (4) expansion and freezing of primary positive clones (up to 50 per fusion), (5) single cell cloning (up to 10 lines per fusion), (6) expansion and freezing of selected lines (10 vials per line) and (7) large scale production of tissue culture supernatants. Professor Jacqueline Lees will be the facility supervisor. All consumables will be covered by chargeback fees. We propose to charge user fees to cover the cost of purchase, housing, immunization and bleeding of mice 2 P30 CA14051-29 29 Dr. Richard O. Hynes ($250 per antigen) and the cost of the hybridoma fusion and antibody production ($1500 per fusion).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014051-31
Application #
6591560
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-05-01
Project End
2003-04-30
Budget Start
Budget End
Support Year
31
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
McConnell, Russell E; Edward van Veen, J; Vidaki, Marina et al. (2016) A requirement for filopodia extension toward Slit during Robo-mediated axon repulsion. J Cell Biol 213:261-74
Puram, Rishi V; Kowalczyk, Monika S; de Boer, Carl G et al. (2016) Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML. Cell 165:303-16
Yin, Hao; Bogorad, Roman L; Barnes, Carmen et al. (2016) RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver. J Hepatol 64:899-907
Hosios, Aaron M; Hecht, Vivian C; Danai, Laura V et al. (2016) Amino Acids Rather than Glucose Account for the Majority of Cell Mass in Proliferating Mammalian Cells. Dev Cell 36:540-9
Jhunjhunwala, Siddharth; Alvarez, David; Aresta-DaSilva, Stephanie et al. (2016) Frontline Science: Splenic progenitors aid in maintaining high neutrophil numbers at sites of sterile chronic inflammation. J Leukoc Biol 100:253-60
Tirosh, Itay; Izar, Benjamin; Prakadan, Sanjay M et al. (2016) Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352:189-96
Stevens, Mark M; Maire, Cecile L; Chou, Nigel et al. (2016) Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate. Nat Biotechnol 34:1161-1167
Sun, Daphne; Dalin, Simona; Hemann, Michael T et al. (2016) Differential selective pressure alters rate of drug resistance acquisition in heterogeneous tumor populations. Sci Rep 6:36198
Kimmerling, Robert J; Lee Szeto, Gregory; Li, Jennifer W et al. (2016) A microfluidic platform enabling single-cell RNA-seq of multigenerational lineages. Nat Commun 7:10220
Lowther, Daniel E; Goods, Brittany A; Lucca, Liliana E et al. (2016) PD-1 marks dysfunctional regulatory T cells in malignant gliomas. JCI Insight 1:

Showing the most recent 10 out of 673 publications